Publikationen von Ulrike Schmidt

Chevalier, C. M.; Krampert, L.; Schreckenbach, M.; Schubert, C. F.; Reich, J.; Novak, B.; Schmidt, M. V.; Rutten, B. P. F.; Schmidt, U.: MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans. EUROPEAN NEUROPSYCHOPHARMACOLOGY 51, S. 20 - 32 (2021)

Herrmann, L.; Ebert, T.; Rosen, H.; Novak, B.; Philipsen, A.; Touma, C.; Schreckenbach, M.; Gassen, N. C.; Rein, T.; Schmidt, U.: Analysis of the cerebellar molecular stress response led to first evidence of a role for FKBP51 in brain FKBP52 expression in mice and humans. NEUROBIOLOGY OF STRESS 15, 100401 (2021)

Weeger, J.; Ising, M.; Mueller-Myhsok, B.; Uhr, M.; Schmidt, U.; Steiger, A.: Salivary cortisol response to psychosocial stress in the late evening depends on CRHR1 genotype. PSYCHONEUROENDOCRINOLOGY 116, 104685 (2020)

Weeger, J.; Ising, M.; Mueller-Myhsok, B.; Uhr, M.; Schmidt, U.; Yassouridis, A.; Steiger, A.: Influence of CRHR1 genotype on sleep and cortisol of healthy volunteers after Trier Social Stress Test in the late evening. JOURNAL OF SLEEP RESEARCH 29, S. 117 - 118 (2020)

Eidhof, M. B.; ter Heide, F. J. J.; van der Aa, N.; Schreckenbach, M.; Schmidt, U.; Brand, B. L.; Lanius, R. A.; Loewenstein, R. J.; Spiegel, D.; Vermetten, E.: The Dissociative Subtype of PTSD Interview (DSP-I): Development and Psychometric Properties. JOURNAL OF TRAUMA & DISSOCIATION 20 (5), S. 564 - 581 (2019)

Schubert, C. F.; Schmidt, U.; Comtesse, H.; Gall-Kleebach, D.; Rosner, R.: Posttraumatic growth during cognitive behavioural therapy for posttraumatic stress disorder: Relationship to symptom change and introduction of significant other assessment. STRESS AND HEALTH 35 (5), S. 617 - 625 (2019)

Schubert, C. F.; Schreckenbach, M.; Kirmeier, T.; Gall-Kleebach, D. J.; Wollweber, B.; Büll, D. R.; Uhr, M.; Rosner, R.; Schmidt, U.: PTSD psychotherapy improves blood pressure but leaves HPA axis feedback sensitivity stable and unaffected: First evidence from a pre-post treatment study. PSYCHONEUROENDOCRINOLOGY 100, S. 254 - 263 (2019)

Naik, R. R.; Sotnikov, S. V.; Diepold, R. P.; Iurato, S.; Markt, P. O.; Bultmann, A.; Brehm, N.; Mattheus, T.; Lutz, B.; Erhardt, A. et al.; Binder, E. B.; Schmidt, U.; Holsboer, F.; Landgraf, R.; Czibere, L.: Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex. TRANSLATIONAL PSYCHIATRY 8, 1 (2018)

Sack, M.; Spieler, D.; Wizelman, L.; Epple, G.; Stich, J.; Zaba, M.; Schmidt, U.: Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC MEDICINE 15, 40 (2017)

Vater, M.; Moeckl, L.; Gormanns, V.; Fademrecht, C. S.; Mallmann, A. M.; Ziegart-Sadowska, K.; Zaba, M.; Frevert, M. L.; Braeuchle, C.; Holsboer, F. et al.; Rein, T.; Schmidt, U.; Kirmeier, T.: New insights into the intracellular distribution pattern of cationic amphiphilic drugs. SCIENTIFIC REPORTS 7, 44277 (2017)

Kirmeier, T.; Gopalakrishnan, R.; Ganal, V.; Werner, A. M.; Cuboni, S.; Rudolf, G. C.; Hoefner, G.; Wanner, K. T.; Sieber, S. A.; Schmidt, U. et al.; Holsboer, F.; Rein, T.; Hausch, F.: Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores. PLOS ONE 11 (2), e0148608 (2016)

Castillo-Gomez, E.; Kaestner, A.; Steiner, J.; Schneider, A.; Hettling, B.; Poggi, G.; Ostehr, K.; Uhr, M.; Asif, A. R.; Matzke, M. et al.; Schmidt, U.; Pfander, V.; Hammer, C.; Schulz, T. F.; Binder, L.; Stoecker, W.; Weber, F.; Ehrenreich, H.: The Brain as Immunoprecipitator of Serum Autoantibodies Against N-Methyl-D-Aspartate Receptor Subunit NR1. ANNALS OF NEUROLOGY 79 (1), S. 144 - 151 (2016)

Schubert, C. F.; Schmidt, U.; Rosner, R.: Posttraumatic Growth in Populations with Posttraumatic Stress Disorder-A Systematic Review on Growth-Related Psychological Constructs and Biological Variables. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY 23 (6), S. 469 - 486 (2016)

Schmidt, U.; Keck, M.; Buell, D. R.: miRNAs and other non-coding RNAs in posttraumatic stress disorder: A systematic review of clinical and animal studies. JOURNAL OF PSYCHIATRIC RESEARCH 65, S. 1 - 8 (2015)

Schmidt, U.: A plea for symptom-based research in psychiatry. EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 6, 27660 (2015)

Zaba, M.; Kirmeier, T.; Ionescu, I. A.; Wollweber, B.; Büll, D. R.; Gall-Kleebach, D. J.; Schubert, C. F.; Novak, B.; Huber, C.; Köhler, K. et al.; Holsboer, F.; Pütz, B.; Müller-Myhsok, B.; Höhne, N.; Uhr, M.; Ising, M.; Herrmann, L.; Schmidt, U.: Identification and characterization of HPA-axis reactivity endophenotypes in a cohort of female PTSD patients. PSYCHONEUROENDOCRINOLOGY 55, S. 102 - 115 (2015)

Dine, J.; Ionescu, I.; Avrabos, C.; Yen, Y.-C.; Holsboer, F.; Landgraf, R.; Schmidt, U.; Eder, M.: Intranasally Applied Neuropeptide S Shifts a High-Anxiety Electrophysiological Endophenotype in the Ventral Hippocampus towards a "Normal"-Anxiety One. PLOS ONE 10 (4), e0120272 (2015)

Schmidt, U.; Buell, D. R.; Ionescu, I. A.; Gassen, N. C.; Holsboer, F.; Cox, M. B.; Novak, B.; Huber, C.; Hartmann, J.; Schmidt, M. V. et al.; Touma, C.; Rein, T.; Herrmann, L.: A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies. PSYCHONEUROENDOCRINOLOGY 52, S. 43 - 58 (2015)

Schmidt, U.; Willmund, G.-D.; Holsboer, F.; Wotjak, C. T.; Gallinat, J.; Kowalski, J. T.; Zimmermann, P.: Searching for non-genetic molecular and imaging PTSD risk and resilience markers: Systematic review of literature and design of the German Armed Forces PTSD biomarker study. PSYCHONEUROENDOCRINOLOGY 51, S. 444 - 458 (2015)

Wollweber, B.; Keck, M. E.; Schmidt, U.: Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases. Therapeutic advances in psychopharmacology 5 (4), S. 208 - 13 (2015)